Adjunctive Medicines

Harris A. Gelbard and Stuart A. Lipton

in The Neurology of AIDS

Third edition

Published on behalf of Oxford University Press

Published in print December 2011 | ISBN: 9780195399349
Published online September 2012 | e-ISBN: 9780199965199 | DOI:
Adjunctive Medicines

More Like This

Show all results sharing these subjects:

  • Disorders of the Nervous System
  • Infectious Diseases


Show Summary Details


Antiretroviral drugs are the only therapy currently in general use for the treatment of HIV-associated neurocognitive disorders (HAND), but the treatment response to these agents may be unsatisfactory or short lived. One reason for this unsatisfactory response may be that the pathophysiology of HAND is initiated by the virus but involves a cascade of ongoing inflammation mediated by peripheral and central immune effector cells, viral neurotoxins, pro-inflammatory cellular metabolites, and by a reduction in normal levels of trophic factors in the central nervous system. Steps in this inflammatory cascade may provide useful targets for adjunctive therapies for HAND. There is a similar need for adjunctive therapies for HIV-associated peripheral neuropathy. This chapter discusses the design of clinical trials for these therapies as well as particular targets and drugs.

Chapter.  9875 words. 

Subjects: Disorders of the Nervous System ; Infectious Diseases

Full text: subscription required

How to subscribe Recommend to my Librarian

Buy this work at Oxford University Press »

Users without a subscription are not able to see the full content. Please, subscribe or login to access all content.